Perasso A, Testino G
Division di Gastroenterologia, Ospedale San Martino, Genova, Italy.
Gastroenterol Jpn. 1991 Oct;26(5):588-92. doi: 10.1007/BF02781674.
Chief cell mass and type I serum pepsinogen (PGI) were calculated in 19 advanced antral gastric cancer of intestinal type. Comparisons were also made with parietal cell mass and acid secretion. In gastric cancer of the antrum there is a significant decrease of the chief cell mass and of serum pepsinogen I. The patients were subdivided according to the histological findings of the fundic mucosa. In cases of antral gastric cancer with superficial fundic gastritis there is normozymogenism with hyperpepsinogenemy; with preatrophic fundic gastritis there is hypozymogenism with normopepsinogenemy; with atrophic fundic gastritis there is hypozymogenism with hypopepsinogenemy. Similar behavior of the chief cell mass between antral gastric cancer and fundic atrophic gastritis without cancer has become recognized and while the validity of PGI as a marker of fundic atrophic gastritis has emerged it does not allow discrimination between atrophic fundic gastritis and atrophic fundic gastritis associated with gastric cancer of the antrum.
对19例进展期肠型胃窦癌患者计算主细胞量和I型血清胃蛋白酶原(PGI),并与壁细胞量和胃酸分泌进行比较。胃窦癌患者的主细胞量和血清胃蛋白酶原I显著降低。根据胃底黏膜的组织学检查结果对患者进行细分。胃窦癌合并浅表性胃底胃炎时,酶原生成正常但胃蛋白酶原增多;合并萎缩前期胃底胃炎时,酶原生成减少但胃蛋白酶原正常;合并萎缩性胃底胃炎时,酶原生成减少且胃蛋白酶原减少。胃窦癌与无癌的胃底萎缩性胃炎之间主细胞量的相似表现已得到认可,虽然PGI作为胃底萎缩性胃炎标志物的有效性已得到证实,但它无法区分萎缩性胃底胃炎和与胃窦癌相关的萎缩性胃底胃炎。